Blood cancers, Cell type, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 1/2
This study looked at combinations of cancer drugs for central nervous system lymphoma. Central nervous system lymphoma is a cancer of the that starts in the brain or spinal cord. This is CNS lymphoma.
This trial was open for people to join between 2015 and 2019. The team published the results in 2021.
Recruitment start: 3 February 2015
Recruitment end: 30 April 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Christopher Fox
Adienne
Bloodwise
Experimental Cancer Medicine Centre (ECMC)
University of Birmingham
Last reviewed: 10 October 2022
CRUK internal database number: 12129